J Clin Neurol.  2017 Jan;13(1):15-20. 10.3988/jcn.2017.13.1.15.

Cardiovascular Autonomic Dysfunction in Patients with Drug-Induced Parkinsonism

• Kim JS
• Ryu DW
• Oh JH
• Lee YH
• Park SJ
• Jeon K
• Lee JY
• Ho SH
• So J
• Im JH
• Lee KS

• KMID: 2364892
• DOI: http://doi.org/10.3988/jcn.2017.13.1.15

Abstract

BACKGROUND AND PURPOSE
Recent studies have shown that several nonmotor symptoms differ between Parkinson's disease (PD) and drug-induced parkinsonism (DIP). However, there have been no reports on cardiovascular autonomic function in DIP, and so this study investigated whether cardiovascular autonomic function differs between PD and DIP patients.
METHODS
This study consecutively enrolled 20 DIP patients, 99 drug-naïve PD patients, and 25 age-matched healthy controls who underwent head-up tilt-table testing and 24-h ambulatory blood pressure monitoring.
RESULTS
Orthostatic hypotension was more frequent in patients with PD or DIP than in healthy controls. In DIP, orthostatic hypotension was associated with the underlying psychiatric diseases and neuroleptics use, whereas prokinetics were not related to orthostatic hypotension. The supine blood pressure, nighttime blood pressure, and nocturnal blood pressure dipping did not differ significantly between the DIP and control groups. Supine hypertension and nocturnal hypertension were more frequent in PD patients than in controls.
CONCLUSIONS
The included DIP patients frequently exhibited orthostatic hypotension that was associated with the underlying diseases as well as the nature of and exposure time to the offending drugs. Clinicians should individualize the manifestations of DIP according to underlying diseases as well as the action mechanism of and exposure time to each offending drug.

Keyword

Parkinson's disease; drug-induced parkinsonism; cardiovascular autonomic dysfunction

MeSH Terms

Antipsychotic Agents
Blood Pressure
Blood Pressure Monitoring, Ambulatory
Humans
Hypertension
Hypotension, Orthostatic
Parkinson Disease
Parkinsonian Disorders*
Tilt-Table Test
Antipsychotic Agents

Reference

1. Shin HW, Chung SJ. Drug-induced parkinsonism. J Clin Neurol. 2012; 8:15–21.

2. Thanvi B, Treadwell S. Drug induced parkinsonism: a common cause of parkinsonism in older people. Postgrad Med J. 2009; 85:322–326.

3. Negrotti A, Calzetti S. A long-term follow-up study of cinnarizineand flunarizine-induced parkinsonism. Mov Disord. 1997; 12:107–110.

4. Lee PH, Kim JS, Shin DH, Yoon SN, Huh K. Cardiac 123I-MIBG scintigraphy in patients with drug induced parkinsonism. J Neurol Neurosurg Psychiatry. 2006; 77:372–374.

5. Tolosa E, Coelho M, Gallardo M. DAT imaging in drug-induced and psychogenic parkinsonism. Mov Disord. 2003; 18:Suppl 7. S28–S33.

6. Kim JS, Lee SH, Oh YS, Park JW, An JY, Park SK, et al. Cardiovascular autonomic dysfunction in mild and advanced Parkinson's disease. J Mov Disord. 2016; 9:97–103.

7. Low PA, Tomalia VA. Orthostatic hypotension: mechanisms, causes, management. J Clin Neurol. 2015; 11:220–226.

8. Kim JS, Youn J, Shin H, Cho JW. Nonmotor symptoms in drug-induced parkinsonism and drug-naïve Parkinson disease. Can J Neurol Sci. 2013; 40:36–41.

9. Brigo F, Erro R, Marangi A, Bhatia K, Tinazzi M. Differentiating drug-induced parkinsonism from Parkinson's disease: an update on non-motor symptoms and investigations. Parkinsonism Relat Disord. 2014; 20:808–814.

10. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry. 1988; 51:745–752.

11. Broadley AJ, Frenneaux MP, Moskvina V, Jones CJ, Korszun A. Baroreflex sensitivity is reduced in depression. Psychosom Med. 2005; 67:648–651.

12. Kemp AH, Quintana DS, Gray MA, Felmingham KL, Brown K, Gatt JM. Impact of depression and antidepressant treatment on heart rate variability: a review and meta-analysis. Biol Psychiatry. 2010; 67:1067–1074.

13. Licht CM, de Geus EJ, Zitman FG, Hoogendijk WJ, van Dyck R, Penninx BW. Association between major depressive disorder and heart rate variability in the Netherlands Study of Depression and Anxiety (NESDA). Arch Gen Psychiatry. 2008; 65:1358–1367.

14. Regan CO, Kearney PM, Cronin H, Savva GM, Lawlor BA, Kenny R. Oscillometric measure of blood pressure detects association between orthostatic hypotension and depression in population based study of older adults. BMC Psychiatry. 2013; 13:266.

15. Dauphinot V, Rouch I, Kossovsky MP, Pichot V, Dorey JM, Krolak-Salmon P, et al. Depressive symptoms and autonomic nervous system dysfunction in an elderly population-based study: the PROOF study. J Affect Disord. 2012; 143:153–159.

16. Perlmuter LC, Sarda G, Casavant V, O'Hara K, Hindes M, Knott PT, et al. A review of orthostatic blood pressure regulation and its association with mood and cognition. Clin Auton Res. 2012; 22:99–107.

17. Mackin P. Cardiac side effects of psychiatric drugs. Hum Psychopharmacol. 2008; 23:Suppl 1. 3–14.

18. Gugger JJ. Antipsychotic pharmacotherapy and orthostatic hypotension: identification and management. CNS Drugs. 2011; 25:659–671.

19. Shin HW, Kim MJ, Kim JS, Lee MC, Chung SJ. Levosulpiride-induced movement disorders. Mov Disord. 2009; 24:2249–2253.

20. Tonini M, Cipollina L, Poluzzi E, Crema F, Corazza GR, De Ponti F. Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics. Aliment Pharmacol Ther. 2004; 19:379–390.

21. Kwon YS, Son M. DA-9701: a new multi-acting drug for the treatment of functional dyspepsia. Biomol Ther (Seoul). 2013; 21:181–189.

22. Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011; 21:69–72.

23. Kaufmann H. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure and multiple system atrophy. Clin Auton Res. 1996; 6:125–126.

24. Oh YS, Kim JS, Lee KS. Orthostatic and supine blood pressures are associated with white matter hyperintensities in Parkinson disease. J Mov Disord. 2013; 6:23–27.

25. Pathak A, Senard JM. Blood pressure disorders during Parkinson's disease: epidemiology, pathophysiology and management. Expert Rev Neurother. 2006; 6:1173–1180.

26. Goldstein DS, Pechnik S, Holmes C, Eldadah B, Sharabi Y. Association between supine hypertension and orthostatic hypotension in autonomic failure. Hypertension. 2003; 42:136–142.

27. Birkenhäger AM, van den Meiracker AH. Causes and consequences of a non-dipping blood pressure profile. Neth J Med. 2007; 65:127–131.

28. Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013; 31:1281–1357.

29. Oh YS, Kim JS, Kim YI, Yang DW, Koo JS, Jung HO, et al. Circadian blood pressure and heart rate variations in de novo Parkinson's disease. Biol Rhythm Res. 2014; 45:335–343.

30. Kim JS, Oh YS, Lee KS, Kim YI, Yang DW, Goldstein DS. Association of cognitive dysfunction with neurocirculatory abnormalities in early Parkinson disease. Neurology. 2012; 79:1323–1331.

31. Kim JS, Park HE, Oh YS, Lee SH, Park JW, Son BC, et al. Orthostatic hypotension and cardiac sympathetic denervation in Parkinson disease patients with REM sleep behavioral disorder. J Neurol Sci. 2016; 362:59–63.

32. Park HE, Kim JS, Oh YS, Park IS, Park JW, Song IU, et al. Autonomic nervous system dysfunction in patients with Parkinson disease having depression. J Geriatr Psychiatry Neurol. 2016; 29:11–17.

33. Oh YS, Kim JS, Park IS, Song IU, Son YM, Park JW, et al. Association between nocturnal/supine hypertension and restless legs syndrome in patients with Parkinson's disease. J Neurol Sci. 2014; 344:186–189.

34. Jain S, Goldstein DS. Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis. Neurobiol Dis. 2012; 46:572–580.

35. Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. 2003; 24:197–211.

36. López-Sendón J, Mena MA, de Yébenes JG. Drug-induced parkinsonism. Expert Opin Drug Saf. 2013; 12:487–496.

37. Grippo AJ, Johnson AK. Biological mechanisms in the relationship between depression and heart disease. Neurosci Biobehav Rev. 2002; 26:941–962.

38. Kim YD, Kim JS, Chung SW, Song IU, Yang DW, Hong YJ, et al. Cognitive dysfunction in drug induced parkinsonism (DIP). Arch Gerontol Geriatr. 2011; 53:e222–e226.